Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

W. J. A. Witlox; B. L. T. Ramaekers; H. J. M. Groen; A. M. Dingemans; J. Praag; J. Belderbos; V. van der Noort; H. van Tinteren; M. A. Joore; D. K. M. De Ruysscher

doi:10.1080/0284186X.2019.1629016

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

W. J. A. Witlox^*
, B. L. T. Ramaekers
, H. J. M. Groen
, A. M. Dingemans
, J. Praag
, J. Belderbos
, V. van der Noort
, H. van Tinteren
, M. A. Joore
, D. K. M. De Ruysscher

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1528-1531
Number of pages	4
Journal	Acta Oncologica
Volume	58
Issue number	10
Early online date	27 Jun 2019
DOIs	https://doi.org/10.1080/0284186X.2019.1629016
Publication status	Published - 3 Oct 2019

Keywords

BRAIN METASTASES
HIGH-RISK
CHEMORADIOTHERAPY
CHEMOTHERAPY
TRIAL

Access to Document

10.1080/0284186X.2019.1629016

https://pure.rug.nl/ws/files/93755276/8_15_2019_Factors_de.pdfLicence: Other

Cite this

Witlox, W. J. A., Ramaekers, B. L. T., Groen, H. J. M., Dingemans, A. M., Praag, J., Belderbos, J., van der Noort, V., van Tinteren, H., Joore, M. A., & De Ruysscher, D. K. M. (2019). Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study. Acta Oncologica, 58(10), 1528-1531. https://doi.org/10.1080/0284186X.2019.1629016

@article{20dffc69992f40ab94b1b811372cafe6,

title = "Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study",

keywords = "BRAIN METASTASES, HIGH-RISK, CHEMORADIOTHERAPY, CHEMOTHERAPY, TRIAL",

author = "Witlox, \{W. J. A.\} and Ramaekers, \{B. L. T.\} and Groen, \{H. J. M.\} and Dingemans, \{A. M.\} and J. Praag and J. Belderbos and \{van der Noort\}, V. and \{van Tinteren\}, H. and Joore, \{M. A.\} and \{De Ruysscher\}, \{D. K. M.\}",

year = "2019",

month = oct,

day = "3",

doi = "10.1080/0284186X.2019.1629016",

language = "English",

volume = "58",

pages = "1528--1531",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "10",

}

Witlox, WJA , Ramaekers, BLT, Groen, HJM, Dingemans, AM, Praag, J, Belderbos, J, van der Noort, V, van Tinteren, H, Joore, MA & De Ruysscher, DKM 2019, 'Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study', Acta Oncologica, vol. 58, no. 10, pp. 1528-1531. https://doi.org/10.1080/0284186X.2019.1629016

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study. / Witlox, W. J. A.; Ramaekers, B. L. T.; Groen, H. J. M. et al.
In: Acta Oncologica, Vol. 58, No. 10, 03.10.2019, p. 1528-1531.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer

T2 - exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

AU - Witlox, W. J. A.

AU - Ramaekers, B. L. T.

AU - Groen, H. J. M.

AU - Dingemans, A. M.

AU - Praag, J.

AU - Belderbos, J.

AU - van der Noort, V.

AU - van Tinteren, H.

AU - Joore, M. A.

AU - De Ruysscher, D. K. M.

PY - 2019/10/3

Y1 - 2019/10/3

KW - BRAIN METASTASES

KW - HIGH-RISK

KW - CHEMORADIOTHERAPY

KW - CHEMOTHERAPY

KW - TRIAL

U2 - 10.1080/0284186X.2019.1629016

DO - 10.1080/0284186X.2019.1629016

M3 - Comment/Letter to the editor

C2 - 31256737

SN - 0284-186X

VL - 58

SP - 1528

EP - 1531

JO - Acta Oncologica

JF - Acta Oncologica

IS - 10

ER -

Witlox WJA , Ramaekers BLT, Groen HJM, Dingemans AM, Praag J, Belderbos J et al. Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study. Acta Oncologica. 2019 Oct 3;58(10):1528-1531. Epub 2019 Jun 27. doi: 10.1080/0284186X.2019.1629016